| Literature DB >> 33105614 |
Monica Ghosh1, Igor A Schepetkin2, Gulmira Özek3, Temel Özek3,4, Andrei I Khlebnikov5,6, Derek S Damron1, Mark T Quinn2.
Abstract
Little is known about the pharmacological activity of Monarda fistulosa L. essential oils. To address this issue, we isolated essential oils from the flowers and leaves of M. fistulosa and analyzed their chemical composition. We also analyzed the pharmacological effects of M. fistulosa essential oils on transient receptor potential (TRP) channel activity, as these channels are known targets of various essential oil constituents. Flower (MEOFl) and leaf (MEOLv) essential oils were comprised mainly of monoterpenes (43.1% and 21.1%) and oxygenated monoterpenes (54.8% and 77.7%), respectively, with a high abundance of monoterpene hydrocarbons, including p-cymene, γ-terpinene, α-terpinene, and α-thujene. Major oxygenated monoterpenes of MEOFl and MEOLv included carvacrol and thymol. Both MEOFl and MEOLv stimulated a transient increase in intracellular free Ca2+ concentration ([Ca2+]i) in TRPA1 but not in TRPV1 or TRPV4-transfected cells, with MEOLv being much more effective than MEOFl. Furthermore, the pure monoterpenes carvacrol, thymol, and β-myrcene activated TRPA1 but not the TRPV1 or TRPV4 channels, suggesting that these compounds represented the TRPA1-activating components of M. fistulosa essential oils. The transient increase in [Ca2+]i induced by MEOFl/MEOLv, carvacrol, β-myrcene, and thymol in TRPA1-transfected cells was blocked by a selective TRPA1 antagonist, HC-030031. Although carvacrol and thymol have been reported previously to activate the TRPA1 channels, this is the first report to show that β-myrcene is also a TRPA1 channel agonist. Finally, molecular modeling studies showed a substantial similarity between the docking poses of carvacrol, thymol, and β-myrcene in the binding site of human TRPA1. Thus, our results provide a cellular and molecular basis to explain at least part of the therapeutic properties of these essential oils, laying the foundation for prospective pharmacological studies involving TRP ion channels.Entities:
Keywords: Monarda fistulosa; TRPA1; calcium flux; carvacrol; essential oils; monoterpene; thymol; β-myrcene
Mesh:
Substances:
Year: 2020 PMID: 33105614 PMCID: PMC7659962 DOI: 10.3390/molecules25214873
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Biological activity of essential oils of Monarda species and their major constituents (literature survey).
| Monarda spp. | Biological Activity | Major Constituents | Ref. |
|---|---|---|---|
| Nematotoxic | Carvacrol, γ-terpinene, | [ | |
| Antifungal | Thymol, carvacrol, α-terpinene, | [ | |
| Phytotoxic | Essential oil | [ | |
| Antimicrobial | Thymol | [ | |
| - | Thymol, thymol methyl ether | [ | |
| Nematotoxic | Carvacrol, γ-terpinene, | [ | |
| Antiseborrheic | Essential oil | [ | |
| Repellent | Carvacrol, thymol, eugenol, carvacrol methyl ether | [ | |
| - | Thymol, carvacrol, thymoquinone | [ | |
| Antifungal | Geraniol, geranial, geranyl formate, | [ | |
| Antioxidant | Essential oil, thymol, carvacrol | [ | |
| Antimicrobial | Thymol | [ | |
|
| - | Geraniol, linalool, thymol, carvacrol, 1,8-cineole | [ |
| Repellent | Carvacrol, carvacrol methyl ether, thymol, eugenol | [ | |
| Antilipase | Carvacrol | [ | |
| Antibacterial | Thymol, | [ | |
| Fungicidal | Thymol | [ | |
| Antimicrobial | Essential oil, hydrolate | [ | |
| Antibacterial | Thymol, 1,8-cineole, α-phellandrene, | [ | |
| Antifungal | β-Caryophyllene, citral, limonene, | [ | |
| Anticancer ( | Essential oil, thymol | [ | |
| Antioxidant, antimicrobial | Essential oil | [ | |
| - | [ | ||
| - | Carvacrol | [ | |
| Antiplasmodial | Essential oil, thymoquinone | [ |
Chemical composition of M. fistulosa essential oils isolated from flowers (MEOFl) and leaves (MEOLv).
| # | RRI | Compound | MEOFl | MEOLv | # | RRI | Compound | MEOFl | MEOLv |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1032 | α-Pinene | 0.7 | 0.4 | 23 | 1497 | α-Copaene | T | t |
| 2 | 1035 | α-Thujene | 2.4 | 1.3 | 24 | 1535 | β-Bourbonene | T | 0.1 |
| 3 | 1076 | Camphene | 0.1 | 0.1 | 25 | 1553 | Linalool | 0.1 | 0.1 |
| 4 | 1118 | β-Pinene | 0.2 | 0.1 | 26 | 1556 | 0.2 | 0.2 | |
| 5 | 1132 | Sabinene | 0.3 | 0.1 | 27 | 1571 | 0.1 | t | |
| 6 | 1159 | δ-3-Carene | 0.2 | 0.1 | 28 | 1590 | Bornyl acetate | T | |
| 7 | 1167 | 3-Heptanone | t | 29 | 1611 | Terpinen-4-ol | 1.1 | ||
| 8 | 1174 | β-Myrcene | 1.4 | 0.8 | 30 | 1614 | Methyl carvacrol | 1.1 | 1.4 |
| 9 | 1176 | α-Phellandrene | 0.3 | 0.2 | 31 | 1638 | T | ||
| 10 | 1183 | t | 32 | 1689 | 0.2 | ||||
| 11 | 1188 | α-Terpinene | 3.8 | 1.7 | 33 | 1704 | γ-Muurolene | t | |
| 12 | 1203 | Limonene | 0.9 | 0.5 | 34 | 1706 | α-Terpineol | 0.2 | 0.1 |
| 13 | 1218 | β-Phellandrene | 0.3 | 0.2 | 35 | 1719 | Borneol | 0.2 | 0.1 |
| 14 | 1255 | γ-Terpinene | 6.8 | 2.5 | 36 | 1726 | Germacrene D | 0.3 | 0.2 |
| 15 | 1266 | 3-Octanone | t | 37 | 1773 | δ-Cadinene | t | ||
| 16 | 1280 | 25.6 | 13.1 | 38 | 1802 | Cumin aldehyde | t | ||
| 17 | 1290 | Terpinolene | 0.1 | 39 | 1864 | 0.1 | |||
| 18 | 1393 | 3-Octanol | 0.1 | 40 | 1889 | Ascaridole | t | ||
| 19 | 1400 | Nonanal | t | 41 | 1940 | 4-Isopropyl salicylaldehyde | t | ||
| 20 | 1408 | 1,3,8 | t | 42 | 1969 | 0.1 | |||
| 21 | 1452 | 1-Octen-3-ol | 1.5 | 0.9 | 43 | 2113 | Cumin alcohol | t | |
| 22 | 1474 | 1 | 0.8 | 44 | 2198 | Thymol | 3.1 | 3.3 | |
| 45 | 2239 | Carvacrol | 45.7 | 71.5 |
The data are presented as relative % by weight for each component that was isolated from M. fistulosa flowers and leaves. RRI, relative retention index calculated on the basis of retention of n-alkanes; %, calculated from flame ionization detector data. Trace amounts (t) were present at <0.1%. # means compound number.
Summary of the chemical compositions of MEOFl and MEOLv.
| Total | MEOFl | MEOLv |
|---|---|---|
| % | ||
| 99.8 | 100 | |
| Monoterpene hydrocarbons | 43.1 | 21.1 |
| Oxygenated monoterpenes | 54.8 | 77.7 |
| Sesquiterpene hydrocarbons | 0.3 | 0.3 |
| Miscellaneous compounds | 1.6 | 0.9 |
Figure 1Monarda essential oils increase [Ca2+]i in HEK transient receptor potential TRPA1 cells. Original representative traces demonstrating the dose-dependent effects of flower essential oil (MEOFl) (A) and leaf essential oil (MEOLv) (B). Arrows indicate the effects of 5 (#1), 10 (#2), 15 (#3), 20 (#4), and 25 (#5) µg/mL of the oils on [Ca2+]i in HEK rTRPA1 cells. Summarized data for the dose-dependent increase in [Ca2+]i are shown in (C) and (D). The data are represented as mean ± SEM (n = 90 cells) from 3 independent experiments.
Figure 2Monarda essential oil-induced increases in [Ca2+]i are blocked by HC-030031 in HEK rTRPA1 cells. (A) and (B) are representative traces showing the effects of pretreatment with the selective TRPA1 blocker HC-030031 (20 µM) on the transient increase in [Ca2+]i in HEK-rTRPA1 cells. Summarized data are shown in (C) and (D), respectively. The data are expressed as changes in the [Ca2+]i influx from baseline to peak [Ca2+]i and plotted as the mean ± SEM. * p < 0.0001 compared to [Ca2+]i elicited after treatment with essential oils. Statistical analysis was performed using an unpaired t-test; n = 90 cells from 3 independent experiments.
Figure 3Monarda essential oil-induced increases in [Ca2+]i are independent of TRPV1 and TRPV4 channels. Representative traces demonstrating the unaltered [Ca2+]i baseline in HEK hTRPV1 (A) and HEK hTRPV4 (B) in the presence of MEOFl (arrow #2) and MEOLv (#3) (25 µg/mL). The TRPV1 agonist capsaicin (100 nM, #1) and the TRPV4 agonist GSK-1016790A (10 µM, #4) were used to confirm the expression of functional TRPV1 and TRPV4 channels in HEK cells. Summarized data are shown in (C) and (D), respectively. The data are expressed as the change in [Ca2+]i influx from baseline to peak [Ca2+]i and plotted as the mean ± SEM. * p < 0.0001 compared to the agonist-induced [Ca2+]i influx. Statistical analysis was performed using one-way analysis of variance; n = 90 cells from 3 independent experiments.
Figure 4TRP agonist- and Monarda essential oil-induced increases in [Ca2+]i are absent in parental HEK cells. Representative trace (A) showing the negligible effect in baseline [Ca2+]i in parental HEK 293 cells treated consecutively with 100 µM of allyl isothiocyanate (AITC) (#1), 100 nM of capsaicin (#2), 10 µM of GSK1016790A (#3), 20 µg/mL of MEOFl (#5), and 20 µg/mL of MEOLv (#6). Receptor-effector coupling was confirmed by treating the cells with 25 µM of ATP (#6). Summarized data comparing the effects of MEOFl and MEOLv on [Ca2+]i in parental HEK 293 and HEK rTRPA1 cells (B). The data are expressed as change in the [Ca2+]i influx from baseline to peak [Ca2+]i and plotted as the mean ± SEM. * p < 0.0001 compared to agonist-induced [Ca2+]i influx. Statistical analysis was performed using two-way analysis of variance; n = 90 cells from 3 independent experiments.
Relative content of constituent monoterpenes in MEOFl and MEOLv and their effects on [Ca2+]i flux in HEK rTRPA1-transfected cells.
| Compound | Composition | HEK Cells | ||
|---|---|---|---|---|
| MEOFl | MEOLv | rTRPA1 | NT | |
| % | [Ca2+]i Change | |||
| α-Pinene | 0.7 | 0.4 | 0.054 ± 0.014 | 0.013 ± 0.002 |
| Camphene | 0.1 | 0.1 | 0.014 ± 0.004 | 0.009 ± 0.001 |
| β-Pinene | 0.2 | 0.1 | 0.012 ± 0.002 | 0.011 ± 0.001 |
| Sabinene | 0.3 | 0.1 | 0.029 ± 0.005 | 0.034 ± 0.004 |
| β-Myrcene | 1.4 | 0.8 | 0.111 ± 0.003 | 0.005 ± 0.001 |
| α-Terpinene | 3.8 | 1.7 | 0.007 ± 0.001 | 0.006 ± 0.001 |
| (-) Limonene | 0.9 | 0.5 | 0.008 ± 0.002 | 0.007 ± 0.001 |
| (+) Limonene | - | - | 0.011 ± 0.002 | 0.009 ± 0.002 |
| γ-Terpinene | 6.8 | 2.5 | 0.034 ± 0.005 | 0.014 ± 0.001 |
| 25.6 | 13.1 | 0.071 ± 0.011 | 0.027 ± 0.001 | |
| Terpinolene | 0.1 | - | 0.034 ± 0.007 | 0.022 ± 0.003 |
| Linalool | 0.1 | 0.1 | 0.037 ± 0.007 | 0.002 ± 0.0003 |
| Terpinen-4-ol | 1.1 | - | 0.046 ± 0.007 | 0.013 ± 0.002 |
| α-Terpineol | 0.2 | 0.1 | 0.010 ± 0.002 | 0.004 ± 0.001 |
| Thymol | 3.1 | 3.3 | 0.849 ± 0.013 | 0.026 ± 0.002 |
| Carvacrol | 45.7 | 71.5 | 0.340 ± 0.012 | 0.061 ± 0.018 |
Values of [Ca2+]i changes are presented as the mean ± S.E.M. of 3 independent experiments, as described in Materials and Methods. The cells were treated with 100 µM of monoterpene, and [Ca2+]i was monitored, as described. NT, nontransfected HEK cells.
Figure 5Monarda constituents carvacrol, thymol, and myrcene induce [Ca2+]i increases in HEK rTRPA1 cells. Representative traces demonstrating the dose-dependent effects of carvacrol (A), thymol (B), and β-myrcene (C) (arrows #1–5 representing 50, 75, 100, 125, and 150 µM of each compound) on [Ca2+]i in HEK rTRPA1 cells. Summarized data for the dose-dependent increases in [Ca2+]i are shown in (D). The data are presented as the mean ± SEM (n = 90 cells) from 3 independent experiments.
Figure 6Monoterpenes do not induce increases in [Ca2+]i in HEK cells expressing TRPV1 and TRPV4 channels. Representative traces demonstrating the unaltered [Ca2+]i baseline in HEK hTRPV1 (A) and HEK hTRPV4 (B) in the presence of 100 µM of carvacrol (#2), thymol (#3), β-myrcene (#4), α-terpinene (#5), and γ-terpinene (#6). Capsaicin (#1), the MTRPV1 agonist, and GSK-1016790A (#7), the TRPV4 agonist, were used to confirm the expressions of the TRPV1 and TRPV4 channels, respectively. Summarized data are shown in (C) and (D) for TRPV1 and TRPV4 HEK cells, respectively. The data are expressed as change in the [Ca2+]i influx from baseline to peak [Ca2+]i and plotted as mean ± SEM. * p < 0.0001 compared to agonist-induced [Ca2+]i influx. Statistical analysis was performed using one-way analysis of variance; n = 90 cells from 3 independent experiments.
Figure 7Docking poses of carvacrol (A), thymol (B), and β-myrcene (C). Superimposed docking poses of carvacrol (green skeleton), thymol (blue skeleton), β-myrcene (yellow), and inactive compound p-cymene (grey) (D). Residues within 6 Å of the center of the search space are shown.